Homeopathy for Major Depressive Disorder: Protocol for N-of-1 Studies

Area of Science:

• Integrative Medicine
• Psychiatry
• Clinical Research Methodology

Background:

• N-of-1 studies offer a rigorous method for evaluating individual patient treatment responses.
• This study utilizes a crossover, double-blind, randomized design to assess interventions.
• Investigating a standardized homeopathy protocol for major depression is the focus.

Purpose of the Study:

• To investigate the effectiveness and safety of a standardized homeopathy protocol in treating major depression.
• To formally assess treatment response at the individual patient level.
• To provide a comprehensive view of homeopathy's efficacy in depression through a series of N-of-1 studies.

Main Methods:

• Ten participants with major depression underwent a crossover, double-blind, placebo-controlled N-of-1 study.
• Participants received individualized homeopathy or placebo over 28 weeks in three blocks (2, 4, 8 weeks).
• Symptom progression was monitored using the Beck Depression Inventory (BDI-II); secondary measures included clinical global impression and health surveys.

Main Results:

• The study design allows for detailed analysis of individual treatment responses to homeopathy versus placebo.
• Data from each participant will be analyzed individually, followed by a meta-analysis of combined results.
• Secondary outcome measures include the Clinical Global Impression Scale and the 12-Item Short-Form Health Survey.

Conclusions:

• Each N-of-1 study contributes unique insights, collectively forming a comprehensive evaluation of the homeopathy protocol.
• The findings aim to broaden the understanding of the effectiveness of the specified homeopathy protocol for depression.
• This methodology provides a detailed, patient-centered approach to evaluating homeopathic treatment for major depressive episodes.